Approval · Notice of Compliance 575 · 2002
APO-HYDROXYQUINE: Notice of Compliance 575
Issued December 9, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 575
- Date
- December 9, 2002
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anti-rheumatic, antimalarial
- Canadian reference product
- PLAQUENIL (Sanofi Canada, Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-HYDROXYQUINE | 02246691 | Marketed |
Medicinal ingredients
- HYDROXYCHLOROQUINE SULFATE 200 MG per TAB